Validation And Life-Cycle Management of A Quantitative Ligand-Binding Assay For The Measurement of Nulojix ^® , A Ctla-4–Fc Fusion Protein, in Renal And Liver Transplant Patients

Abstract

This long-term pharmacokinetic program provides a good example of the dynamic clinical environment and adaptation requirements of ligand-binding assays.